Malaysian Genomics Resource Centre Berhad (KLSE:MGRC)

Malaysia · Delayed Price · Currency is MYR

0.3100

-0.0050 (-1.59%)

At close: Nov 2, 2026

Market Cap	46.79M +70.5%
Revenue (ttm)	10.08M +80.4%
Net Income	536.83K
EPS	0.00
Shares Out	150.93M
PE Ratio	83.27
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	100,000
Open	0.3150
Previous Close	0.3150
Day's Range	0.3100 - 0.3150
52-Week Range	0.1550 - 0.3850
Beta	0.15
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 24, 2026

About KLSE:MGRC

Malaysian Genomics Resource Centre Berhad, together with its subsidiaries, provides genetics, genomics, immunotherapy, and biopharmaceutical services in Malaysia. The company offers genetic screening services that includes Dtect and Origene genetic testing solutions which provides individuals with insights into genetic predispositions related to health risks, wellness, and lifestyle traits. It also provides immunotherapy and cell therapy which offers mesenchymal stem cells derived from ethically sourced human umbilical cords, as well as natural... [Read more]

Industry Commercial Physical and Biological Research

Founded 2004

Employees 33

Stock Exchange Bursa Malaysia

Ticker Symbol MGRC

Full Company Profile

Financial Performance

In 2025, KLSE:MGRC's revenue was 8.02 million, an increase of 45.29% compared to the previous year's 5.52 million. Losses were -2.38 million, -43.19% less than in 2024.

Financial Statements